1 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
A new therapeutic antibody with a personalised medicine approach in cardiovascular disease (CARDIMMUN)
Date du début: 1 août 2013, Date de fin: 31 juil. 2016,
... Additionally, studies in man are planned that explores safety, pharmacokinetics, pharmacodynamics and indices of clinical efficacy, including a placebo-controlled Proof of Activity trial in patients.Athera’s PC-mAb is targeting the market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. According to plan, the data will enable a business agreemen ...
Voir le projet